Morningstar
RecommendedSign Up to Our Newsletters Open Window IconMorningstar's Guide to Investing in Stocks Arrow Right
ETF Investing Ideas & News

The Best China Equity ETFs

HSBC, iShares and Amundi make the list as China equity ETFs saw record monthly inflows in February.

Valerio Baselli 28 March, 2025 | 9:39AM
Facebook Twitter LinkedIn
Font-Size

illustration av en flagga med diagramikoner och tidsserielinjer.

Exchange-traded funds can offer a simple and inexpensive way to gain exposure to the stock market. These strategies offer exposure to Chinese equities with a large and mid-market capitalization and are considered promising by Morningstar’s fund analysts.

Indeed, European investors are already showing signs of souring on US stocks against the backdrop of Trump’s trade wars, starting to shift money from the US to Europe and China in particular.

Europe-domiciled ETFs focused on Chinese stocks have attracted almost EUR 3.8 billion of net inflows year-to-date, which compares with EUR 1.05 billion of net outflows seen in 2024. February 2025 saw the best monthly result in terms of flows ever recorded for the category.

In general, flows follow performances. And looking at recent returns, such a recovery in interest in China is logical. Since the start of the year, the Chinese equity market – pushed by tech stocks – has performed exceptionally well, after a long period of underperformance.

A Gold Medalist Rating means our analysts believe a fund has the greatest chance of outperforming its category over the long term, while a Silver or a Bronze rating means they believe it will outperform its relevant performance benchmark and/or peer group.

In the case of China equity ETFs, we have three different providers making the list:

  • HSBC MSCI China UCITS ETF HMCH 
  • iShares MSCI China UCITS ETF USD Dist ICHD 
  • Amundi MSCI China UCITS ETF Acc LCCN 

Screening for the Best China Equity ETFs

We screened for ETFs with Gold, Silver or Bronze Medalist Ratings that are 100% assigned by Morningstar analysts (rather than indirectly or quantitatively assigned). None of the three ETFs that made it through the screen hold a Medalist Rating of Gold or Silver, nor are they actively managed.

All of them track the MSCI China NR Index, which captures large and mid-cap representation across China A shares, H shares, B shares, Red chips, P chips and foreign listings (e.g. ADRs). With 580 constituents, the index covers about 85% of this China equity universe. Currently, the index includes Large Cap A and Mid Cap A shares represented at 20% of their free float adjusted market capitalization.

Here’s a closer look at the strategies:

HSBC MSCI China UCITS ETF HMCH


The £871.7 million HSBC MSCI China UCITS ETF rose 42.01% over the past year. The fund beat its benchmark, the Morningstar China Target Market Exposure Index, by 5.32 percentage points. Year to date, the HSBC fund rose 14.18%, while the average fund in its category is up 8.89%.

iShares MSCI China UCITS ETF USD Dist ICHD


The iShares MSCI China UCITS ETF gained 39.21% over the past year, outperforming the average fund in the China equity category, which rose 25.4%. The fund placed in the fourth percentile for performance and beat its benchmark, the Morningstar China Target Market Exposure Index, by 2.52 percentage points. The £3.2 billion fund has gained 12.46% year to date, while the average fund in its category is up 8.89%.

Amundi MSCI China UCITS ETF Acc LCCN


Over the past year, the passively managed Amundi MSCI China UCITS ETF rose 42.46%, while the average China equity fund gained 25.4%. The fund placed in the second percentile for performance and beat its benchmark by 5.77 percentage points. The £544 million fund has climbed 15.53% year to date, outperforming the average fund in its category, which rose 8.89%.


The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn
Font-Size

About Author

Valerio Baselli

Valerio Baselli  is Senior International Editor at Morningstar.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures

The Morningstar Star Rating for Stocks is assigned based on an analyst's estimate of a stocks fair value. It is projection/opinion and not a statement of fact. Morningstar assigns star ratings based on an analyst’s estimate of a stock's fair value. Four components drive the Star Rating: (1) our assessment of the firm’s economic moat, (2) our estimate of the stock’s fair value, (3) our uncertainty around that fair value estimate and (4) the current market price. This process culminates in a single-point star rating that is updated daily. A 5-star represents a belief that the stock is a good value at its current price; a 1-star stock isn't. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Morningstar Star Rating for Stocks, please visit here

Quantitative Fair Value Estimate represents Morningstar’s estimate of the per share dollar amount that a company’s equity is worth today. The Quantitative Fair Value Estimate is based on a statistical model derived from the Fair Value Estimate Morningstar’s equity analysts assign to companies which includes a financial forecast of the company. The Quantitative Fair Value Estimate is calculated daily. It is a projection/opinion and not a statement of fact. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Quantiative Fair Value Estimate, please visit here

The Morningstar Medalist Rating is the summary expression of Morningstar’s forward-looking analysis of investment strategies as offered via specific vehicles using a rating scale of Gold, Silver, Bronze, Neutral, and Negative. The Medalist Ratings indicate which investments Morningstar believes are likely to outperform a relevant index or peer group average on a risk-adjusted basis over time. Investment products are evaluated on three key pillars (People, Parent, and Process) which, when coupled with a fee assessment, forms the basis for Morningstar’s conviction in those products’ investment merits and determines the Medalist Rating they’re assigned. Pillar ratings take the form of Low, Below Average, Average, Above Average, and High. Pillars may be evaluated via an analyst’s qualitative assessment (either directly to a vehicle the analyst covers or indirectly when the pillar ratings of a covered vehicle are mapped to a related uncovered vehicle) or using algorithmic techniques. Vehicles are sorted by their expected performance into rating groups defined by their Morningstar Category and their active or passive status. When analysts directly cover a vehicle, they assign the three pillar ratings based on their qualitative assessment, subject to the oversight of the Analyst Rating Committee, and monitor and reevaluate them at least every 14 months. When the vehicles are covered either indirectly by analysts or by algorithm, the ratings are assigned monthly. For more detailed information about these ratings, including their methodology, please go to here

The Morningstar Medalist Ratings are not statements of fact, nor are they credit or risk ratings. The Morningstar Medalist Rating (i) should not be used as the sole basis in evaluating an investment product, (ii) involves unknown risks and uncertainties which may cause expectations not to occur or to differ significantly from what was expected, (iii) are not guaranteed to be based on complete or accurate assumptions or models when determined algorithmically, (iv) involve the risk that the return target will not be met due to such things as unforeseen changes in changes in management, technology, economic development, interest rate development, operating and/or material costs, competitive pressure, supervisory law, exchange rate, tax rates, exchange rate changes, and/or changes in political and social conditions, and (v) should not be considered an offer or solicitation to buy or sell the investment product. A change in the fundamental factors underlying the Morningstar Medalist Rating can mean that the rating is subsequently no longer accurate.

For information on the historical Morningstar Medalist Rating for any managed investment Morningstar covers, please contact your local Morningstar office.

For more detailed information about conflicts of interest, including EU MAR disclosures, please see the “Morningstar Medalist Rating Analyst Conflict of Interest & Other Disclosures for EMEA”here

Select Your Site Edition To make sure the site is relevant to you, we need to know if you’re an individual investor or a financial professional.